229 related articles for article (PubMed ID: 12189362)
21. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.
Lötsch J; Stockmann A; Kobal G; Brune K; Waibel R; Schmidt N; Geisslinger G
Clin Pharmacol Ther; 1996 Sep; 60(3):316-25. PubMed ID: 8841154
[TBL] [Abstract][Full Text] [Related]
22. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
[TBL] [Abstract][Full Text] [Related]
23. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
Stain-Texier F; Sandouk P; Scherrmann JM
Drug Metab Dispos; 1998 May; 26(5):383-7. PubMed ID: 9571218
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration.
Lötsch J; Weiss M; Kobal G; Geisslinger G
Clin Pharmacol Ther; 1998 Jun; 63(6):629-39. PubMed ID: 9663177
[TBL] [Abstract][Full Text] [Related]
25. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
27. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
28. Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide.
Bourasset F; Scherrmann JM
Life Sci; 2006 Apr; 78(20):2302-14. PubMed ID: 16309712
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
30. Morphine Glucuronidation and Elimination in Intensive Care Patients: A Comparison with Healthy Volunteers.
Ahlers SJ; Välitalo PA; Peeters MY; Gulik Lv; van Dongen EP; Dahan A; Tibboel D; Knibbe CA
Anesth Analg; 2015 Nov; 121(5):1261-73. PubMed ID: 26332855
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma.
Chapman DJ; Joel SP; Aherne GW
J Pharm Biomed Anal; 1994 Mar; 12(3):353-60. PubMed ID: 8031935
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
[TBL] [Abstract][Full Text] [Related]
33. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
[TBL] [Abstract][Full Text] [Related]
35. Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
Illum L; Davis SS; Pawula M; Fisher AN; Barrett DA; Farraj NF; Shaw PN
Biopharm Drug Dispos; 1996 Nov; 17(8):717-24. PubMed ID: 8950049
[TBL] [Abstract][Full Text] [Related]
36. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
[TBL] [Abstract][Full Text] [Related]
37. Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: relationship to nonanalgesic actions.
Westerling D; Persson C; Höglund P
Ther Drug Monit; 1995 Jun; 17(3):287-301. PubMed ID: 7624926
[TBL] [Abstract][Full Text] [Related]
38. Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.
Okura T; Saito M; Nakanishi M; Komiyama N; Fujii A; Yamada S; Kimura R
Br J Pharmacol; 2003 Sep; 140(1):211-7. PubMed ID: 12967951
[TBL] [Abstract][Full Text] [Related]
39. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
Handal M; Ripel A; Aasmundstad T; Skurtveit S; Mørland J
Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
[TBL] [Abstract][Full Text] [Related]
40. The bioavailability of morphine applied topically to cutaneous ulcers.
Ribeiro MD; Joel SP; Zeppetella G
J Pain Symptom Manage; 2004 May; 27(5):434-9. PubMed ID: 15120772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
